Biochemical markers of bone turnover during hormone replacement therapy

International Journal of Gynecology and Obstetrics

Volumn 64, Issue 2, 1999, Pages 163-166

  Masahashi, T ^a   Negoro, Y ^a   Kuroki, T ^a   Asai, M ^a   Noguchi, M ^a   Nakanishi, M ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone mineral density; Bone turnover marker; Hormone replacement therapy; Postmenopausal women

Indexed keywords

BIOCHEMICAL MARKER; DEOXYPYRIDINOLINE; ESTROGEN; OSTEOCALCIN; PYRIDINOLINE;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; DEMINERALIZATION; DIAGNOSTIC VALUE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; LUMBAR SPINE; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; URINE LEVEL;

EID: 0033016136     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(98)00249-5     Document Type: Article

References (9)

1. Hassager C, Jensen SB, Christiansen C Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: do they exist? Osteoporosis Int. 4:1994;36-41.
2. Rosen CJ, Chesnut III CH, Mallinak NJS The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab. 82:1997;1904-1910.
3. Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe Aet al. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res. 8:1993;881-889.
4. Fledelius C, Riis BJ, Overgaard K, Cristiansen C The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. Calcif Tissue Int. 54:1993;381-384.
5. Riis BJ, Overgaard K, Christiansen C Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy. Osteoporosis Int. 5:1995;276-280.
6. Ohta H, Masuzawa T, Ikeda T, Suda Y, Makita K, Nozawa S Which is more osteoporosis-inducing, menopause or oophorectomy? Bone Miner. 19:1992;273-285.
7. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol. 85:1995;529-537.
8. Hashimoto K, Nozaki M, Yokoyama M, Sano M, Nakano H Urinary excretion of pyridinium crosslinks of collagen in oophorectomized women as markers for bone resorption. Maturitas. 18:1994;135-142.
9. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JLet al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 81:1996;3366-3371.